Cardiogenic shock (CS) remains a critical issue in hospitals nationwide. Despite advances in interventional cardiology, CS is a high-mortality condition, with mortality ranges from 30% to 40%, and 1-year mortality approaches or exceeds 50%. One of the main challenges is the rapid progression of CS severity. Historically, staging using the Society for Cardiovascular Angiography and […]

Cardiogenic shock (CS) remains a critical and life-threatening condition, characterized by a rapid decline in cardiac function and multi-organ dysfunction, often leading to high mortality rates. Despite advancements in critical care, its intricate and rapidly evolving nature presents a formidable clinical challenge. Early identification and prompt intervention are paramount for improved patient outcomes. However, the […]

Cardiogenic shock (CS) represents a profound and often fatal complication in hospitalized patients, with short-term mortality rates persisting at a concerning 40% to 50%. Despite significant advancements in cardiovascular critical care and interventional cardiology, its intricate and rapidly evolving nature continues to present a formidable clinical challenge. Crucially, the initial manifestations of CS are frequently […]

Cardiogenic shock (CS) remains a critical issue in hospitals nationwide, primarily due to delayed identification, which leads to poor patient outcomes. Despite advances in diagnosis and treatment, CS still results in an unacceptably high death rate, with short-term mortality rates at around 40–50%. The condition increases the mortality of patients with acute myocardial infarction (AMI) […]